Skip to main content
Equibles
CABR logo

CABR · Caring Brands, Inc. · Metrics

Track CABR — free

Use CABR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CABR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.40 +0.05 (+3.70%)
Rebalance outlook locked
Market Cap
$12.23M
Shares
10.37M

CABR metrics

47 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.35
Market cap
$12.23M

Price action

20 metrics
Price change (1W)
+8.9%
Price change (30D)
-10.3%
Price change (3M)
-5.1%
Price change (6M)
+25.3%
Price change (YTD)
+42.2%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
123.8%
Annualized volatility (3M)
86.8%
Beta
0.7
RSI (14D)
45.4
Price vs SMA 50
-10.6%
Price vs SMA 200
+8.8%
Avg volume (3M)
67,513
Relative volume
0.4
Average dollar volume
$92,401

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
10.37M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2,902.6×
reciprocal yield 0.0%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-63.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
55.6%
Operating margin
-140,807.2%
Trailing 12 months
Net margin
-148,948.8%
Gross profit (TTM)
$2,342
Operating profit (TTM)
−$7.10M
Net income (TTM)
−$7.73M
Trailing 12 months
Diluted EPS (TTM)
$-0.74
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
$0.00
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.14

Growth

11 metrics
Revenue growth YoY
-9.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4,215
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-32.6%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-404.6%
Debt / equity
—
Current ratio
5.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
4.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.82M
Total assets
$1.91M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$2.26M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$210,927
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
10
13F filer change QoQ
+4
Institutional ownership
1.5%

Short interest

3 metrics
Short interest
0.2%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
50 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 2020737 CUSIP 14216J109 Visit website Investor relations